These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28062334)

  • 1. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
    Brand DA; Patrick PA; Berger JT; Ibrahim M; Matela A; Upadhyay S; Spiegler P
    J Pain Symptom Manage; 2017 May; 53(5):938-943. PubMed ID: 28062334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock.
    Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I;
    Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
    Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
    Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of vasopressor initiation and mortality in septic shock: a cohort study.
    Beck V; Chateau D; Bryson GL; Pisipati A; Zanotti S; Parrillo JE; Kumar A;
    Crit Care; 2014 May; 18(3):R97. PubMed ID: 24887489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressor Cumulative Dose Requirement and Risk of Early Death During Septic Shock: An Analysis From The EPISS Cohort.
    Dargent A; Nguyen M; Fournel I; Bourredjem A; Charles PE; Quenot JP;
    Shock; 2018 Jun; 49(6):625-630. PubMed ID: 29040212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Hyperoncotic Albumin on Duration of Vasopressor Support in Septic Shock: A Propensity Score-Matched Analysis.
    Flannery AH; Owen GD; Coz A; Thompson Bastin ML; Patel K
    Ann Pharmacother; 2021 May; 55(5):584-591. PubMed ID: 33016080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
    Zechmeister C; Hurren J; McNorton K
    Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock.
    DeMott JM; Patel G; Lat I
    Ann Pharmacother; 2018 Jan; 52(1):40-47. PubMed ID: 28799416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality trends in U.S. adults with septic shock, 2005-2011: a serial cross-sectional analysis of nationally-representative data.
    Goto T; Yoshida K; Tsugawa Y; Filbin MR; Camargo CA; Hasegawa K
    BMC Infect Dis; 2016 Jun; 16():294. PubMed ID: 27301657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study.
    Subramanian S; Yilmaz M; Rehman A; Hubmayr RD; Afessa B; Gajic O
    Intensive Care Med; 2008 Jan; 34(1):157-62. PubMed ID: 17924093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
    Fawzy A; Evans SR; Walkey AJ
    Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
    Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
    Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
    Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
    J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
    Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
    Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.